Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
At the end of July, CCRD announced its intention to sell itself to Euronet Worldwide (EEFT) in an all-stock deal valued at $30 / share. Our returns were...
— Avram Fisher
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on CoreCard Corporation
No other institutional pitches found for this ticker yet.
More institutional theses from Long Cast Advisers
With that in mind, and with earnings season in gear, Zimmer’s CEO recently shared positive commentary about the upcoming launch of its new robotic TKA platform on which PDEX, our largest holding, will be a major supplier: We recently announced a multi-year limited distribution and supply agreement with THINK Surgical to distribute an exclusive version of the only wireless handheld TMINI Miniature Robotic System compatible with Persona Knee. Most excitingly, we...
MTRX remains a top five holding despite the stock declining 30% in the quarter. I had expected...
RSSS, which has declined nearly 40% year to date, is no longer at top-five holding but remains a large position nonetheless. It is also...